In addition to treating type 2 diabetes, Semaglutide has also been approved for weight management in people who are overweight or obese and have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol
Two germline GLP-1 signaling transcriptional targets, lst-1 and sygl-1 , have been identified that are redundantly required to promote the stem cell fate through a candidate gene approach [20,21]
Otterbein LEBFH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Patients considering GLP-1 therapy should also understand potential side effects: nausea, vomiting, dehydration, and rare but serious pancreatitis or gallbladder complications
Annals of the New York Academy of Sciences 1194:27-33
What's the difference between the Microdose GLP-1 Protocol and standard injections